CoChat

( 2R,6R )-hydroxynorketamine exerts mGlu 2 receptor-dependent antidepressant actions

Open access

The DOI matches its Crossref record; 110 of the 110 references it cites were found in a registry or an index.

Abstract

Significance: Despite available medications for depression, currently approved antidepressants take months to exert therapeutic effects, and ∼30% of patients remain treatment resistant. In contrast, a single subanesthetic dose of ketamine exerts rapid (within hours) and sustained antidepressant actions. Preclinical studies indicate that the ketamine metabolite ( 2R , 6R )-hydroxynorketamine [( 2R , 6R )-HNK] is a rapid-acting antidepressant candidate with limited adverse effects compared with ketamine. Using behavioral, genetic, and pharmacological approaches and EEG measurements, we determined that the mechanism underlying antidepressant-relevant actions of ( 2R , 6R )-HNK converges with metabotropic glutamate receptor subtype 2 (mGlu 2 ) receptor signaling and identified high-frequency EEG oscillations as a marker associated with rapid antidepressant responses. Our data support the use of individually subtherapeutic doses of mGlu 2 receptor inhibitors with ketamine or ( 2R , 6R )-HNK in clinical trials for the treatment of depression.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1073/pnas.1819540116

Cites

110 of 110 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 110 references

Cited by

See all 154

Metadata

Authors
Zanos, P., Highland, J. N., Stewart, B. W., Georgiou, P., Jenne, C. E., Lovett, J., Morris, P. J., Thomas, C. J., Moaddel, R., Zarate, C. A., & Gould, T. D.
Affiliations
  • University of Maryland, Baltimore (US)
  • National Institutes of Health (US)
Venue
Proceedings of the National Academy of Sciences
Published
2019-03-13
Volume
116
Issue
13
Pages
6441-6450
ISSN
  • 0027-8424 (ISSN-L)
  • 1091-6490
OpenAlex
W2922048335
Cited by
152
References
110
Citations by year
2026: 14 · 2025: 16 · 2024: 12 · 2023: 22 · 2022: 27 · 2021: 25 · 2020: 24 · 2019: 11
FWCI
13.78
Type
journal article
Language
en
Open access
Locations
  • Proceedings of the National Academy of Sciences (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Brain and Behavior Research Foundation (26826)
  • HHS | NIH | National Institute of Mental Health (MH107615)
  • U.S. Department of Veterans Affairs (1I01BX004062)
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
  • Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
Keywords
(2R,6R)-hydroxynorketamine, ketamine metabolites, mGlu2 receptor, metabotropic glutamate receptors, antidepressant effects, rapid-acting antidepressants, depression, treatment-resistant depression, ketamine
MeSH terms
Amino Acids, Animals, Antidepressive Agents, Behavior, Animal, Depression, Disease Models, Animal, Drug Resistance, Female, Fever, Ketamine, Male, Mice, Inbred C57BL, Receptors, N-Methyl-D-Aspartate, Receptors, Metabotropic Glutamate, Mice, Knockout, Bridged Bicyclo Compounds, Heterocyclic, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: ( 2R,6R )-hydroxynorketamine exerts mGlu 2 receptor-dependent antidepressant actions. https://app.cochat.ai/papers/10.1073/pnas.1819540116
The paper
Zanos, P., Highland, J. N., Stewart, B. W., Georgiou, P., Jenne, C. E., Lovett, J., Morris, P. J., Thomas, C. J., Moaddel, R., Zarate, C. A., & Gould, T. D. (2019). ( 2R,6R )-hydroxynorketamine exerts mGlu 2 receptor-dependent antidepressant actions. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.1819540116

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.